Small molecule α(v) integrin antagonists: Novel anticancer agents

Expert Opinion on Investigational Drugs

Volumn 9, Issue 6, 2000, Pages 1271-1279

  Kerr, J S ^a   Slee, A M ^a   Mousa, S A ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Angiogenesis; Cancer; Integrin; (v)

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CYCLOPEPTIDE; INTEGRIN; SCLEROPROTEIN;

ANGIOGENESIS; CANCER; EXTRACELLULAR MATRIX; EYE DISEASE; HEART FAILURE; HUMAN; METASTASIS; MOLECULAR SIZE; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SOLID TUMOR; STROKE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 0034086214     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.6.1271     Document Type: Review

References (112)